Investor Presentaiton
44
Médica Sur
Consolidated Financial Statements and
other Integral Results
Médica Sur, S.A.B. de C.V. and Subsidiaries
Year terms ended on December 31st of 2017 and 2016
(Pesos)
Note
2017
Consolidated Cash Flow Statements
Médica Sur, S.A.B. de C.V. and Subsidiaries
Year terms ended on December 31st of 2017 and 2016
(Pesos)
Notes
2017
2017 Annual Report
45
2016
Operation activities cash flow:
Net profit
Adjustments by:
$
231,870,092 $ 146,210,922
Net cost of the period of employee benefits
Depreciation and amortization
13 and 14
(12,759,011)
220,440,656
15,031,944
325,247,154
Transport equipment and other asset sales loss
(1,758,707)
Profit taxes
2016
Interest in favor
120,428,082
(5,676,881)
107,917
53,519,878
(15,110,169)
Financial activities related item
Services Income
Services Costs
Consolidated gross profit
$ 3,431,445,846 $ 2,510,362,515
2,268,545,024
1,162,900,822
1,733,753,756
776,608,759
Interest expense
Sub total
Accounts receivable, net
Expenses:
Fundación Clínica Médica Sur, A.C..
141,851,298
694,395,529
(70,427,252)
(130,182)
26,877,608
551,885,254
(4,108,574)
95,606
Sales and administration expenses
663,185,180
565,400,468
Other accounts receivable
(23,437,105)
(42,821,646)
Other expenses, net
23
(13,392,260)
(4,079,640)
Total of expenses
649,792,920
561,320,828
Consolidated operation profit
513,107,902
215,287,931
Income and financial costs
(Loss) currency exchange gain, net
Interest expenses
(268,560)
(141,851,298)
Interest income
Financial Costs, net
24
5,676,881
(136,442,977)
19,718,382
(6,547,897)
Consolidated profit before profit taxes, discontinued
operations and other integral results
376,664,925
208,740,034
614,576
(26,880,855)
Inventories, net
Insurance paid in advance
Suppliers
Taxes and accumulated expenses
Contingent liability provisions
Net cash flow of operation activities
Taxes expenses
Interest expenses
Net cash flow from operating activities
Investment activities:
(16,121,154)
1,487,033
(24,208,083)
(10,172,043)
(55,117,703)
(204,087,506)
(4,707,748)
(7,484,573)
80,594,487
15,436,374
518,456,845
362,613,869
(170,474,322)
(143,192,000)
(133,996,659)
(20,639,728)
213,985,864
198,782,141
Profit taxes
18
120,428,082
55,491,361
Increases in other fixed assets, net
Interrupted operation
25
(24,366,751)
(7,037,751)
Interest received
Consolidated net profit
231,870,092
146,210,922
Resources received in real estate, furniture and equipment sales
Other integral results:
Received deposits
5,676,881
75,944,248
100,454,051
4,837,391
15,110,169
(Losses) actuary profit, net of profit taxes
17
Consolidated Integral Profit
(2,090,067)
229,780,025
1,936,970
148,147,892
Real estate, furniture, equipment and investment properties acquisitions
Receivable payments or entity share recovery
13 y 14
(266,079,788)
(456,700)
(230,325,263)
Net consolidated profit imputable to:
Business acquisitions
Controlling share
Non-controlling share
231,798,220
71,872
231,870,092
142,634,010
3,576,912
146,210,922
Net cash flow used in investment activities
(1,447,493,000)
(84,461,308) (1,657,870,703)
Financing activities:
Integral consolidated profit imputable to:
Controlling share
Non-controlling share
Basic and diluted per share profit
Number of average weighted shares
See notes attached to the consolidated financial statements
22 $
229,708,153
71,872
229,780,025
144,570,980
3,576,912
148,147,892
1.88
1.19
123,281,750 $ 123,281,750
Obtained loans
16
Paid dividends
20
Net cash flow (used in) generated by financing activities
Cash flow net increase (decrease) and cash equivalents
Cash and cash equivalents:
65,000,000 1,285,000,000
(82,137,976) (80,729,079)
(17,137,976) 1,204,270,921
112,386,580 (254,817,641)
At the beginning of the year
At the end of the year
104,310,067
359,127,708
9 $
216,696,647 $ 104,310,067
See notes attached to the consolidated financial servicesView entire presentation